alternet logo

Tough Times

Demand honest news. Help support AlterNet and our mission to keep you informed during this crisis.

big pharma

With just one vote, Susan Collins made $7 billion for four big pharmaceutical companies — here's how

Remember how Sen. Susan Collins gave her “yes” vote on the GOP tax scam to Senate Majority Leader Mitch McConnell on the ironclad promise that he'd do something to protect people with pre-existing conditions? That worked out well. So did the tax cuts Collins helped pass—for big pharmaceuticals, that is. An Oxfam report details how four pharmaceutical giants—Johnson & Johnson, Pfizer, Merck, and Abbott Laboratories—netted $7 billion in tax cuts from two central provisions. "This corporate gain," the report says, "comes at a massive public loss, especially to the health and well-being of women and girls."

Keep reading... Show less

Big pharma greed and bad government policy are hampering global efforts to end AIDS

If you cure illnesses, said Goldman Sachs Vice President Salveen Richter, it will disrupt “sustained cash flow.” Far better to find medical treatments that provide some solace but that prolong illnesses. Even better if these treatments are both necessary and expensive. If you find a cure for an illness, then you will find—as Richter wrote in her analysis for Goldman Sachs—“a gradual exhaustion of the prevalent pool of patients.” That’s the worst thing imaginable for pharmaceutical companies and their investors. Keep the goose alive as long as it keeps laying golden eggs.

Keep reading... Show less

America’s Seniors Are Drowning in Lies by Trump and Republicans to Boost Big Pharma

Medicare is a very popular program, far more so than for-profit insurance. It’s also highly effective—the senior poverty rate has dropped dramatically since it was created. But it is not perfect, which is why we must improve and expand the existing system. We must add vision, dental and hearing coverage. We must get rid of out-of-pocket expenses. 

Keep reading... Show less

FDA Repays Big Pharma By Rushing Risky Drugs to Market

Nuplazid, a drug for hallucinations and delusions associated with Parkinson’s disease, failed two clinical trials. In a third trial, under a revised standard for measuring its effect, it showed minimal benefit. Overall, more patients died or had serious side effects on Nuplazid than after receiving no treatment.

Keep reading... Show less

Expanding Medicare to Everyone Is the Only Way We Can Fully Protect It

Medicare is under attack. The only way to fully protect it is to expand it to everyone.

Keep reading... Show less

Trump’s New Drug Pricing Plan is Just Another 'Nonsensical' Scam Designed to Blame Foreigners

Trump promised to rein in drug prices. It was his only sensible campaign promise.

Keep reading... Show less

How Big Pharma Deceives You About Drug Safety

The recent decision of a Saskatchewan judge to reject the proposed settlement between the provinces and Purdue Pharma, the maker of OxyContin, should raise serious questions.

Keep reading... Show less

Trump Launches a New Drug War, Targeting the Opioid Crisis -- But Who's the Real Enemy?

In a characteristically incoherent speech last month, President Donald Trump displayed all the signs of a wannabe despot while outlining his plan to combat the opioid crisis, hich included the controversial call to execute drug dealers. “If we don't get tough on the drug dealers we are wasting our time, and that toughness includes the death penalty,” declared the president, who praised other countries where drug dealers are put to death, such as China, Singapore and the Philippines. “You take a look at some of these countries where they don’t play games. They don’t have a drug problem.”

Keep reading... Show less

If You Want to Kill Drug Dealers, Start With Big Pharma

At a recent rally in New Hampshire, Donald Trump called for the death penalty for drug traffickers as part of a plan to combat the opioid epidemic in the United States. At a Pennsylvania rally a few weeks earlier, he called for the same.

Keep reading... Show less

Why Is UCLA Doing Big Pharma's Dirty Work in India?

On the morning of March 14, a first-year UCLA medical student named Kayla Gu approached the microphone at a meeting of her university’s Board of Regents. Speaking in a white coat with a stethoscope around her neck, she urged the university to drop a patent claim pending at India’s high court, which the David Geffen School of Medicine filed in order to block generic production of the prostate cancer drug enzalutamide, trade name Xtandi. Though developed at UCLA with tens of millions in funding from the National Institutes of Health and the U.S. Army, the drug giant Pfizer is making billions in profits by pricing a standard course of the drug at $130,000.

Keep reading... Show less

The Sick Paying for the Healthy: How Insurance Companies Drive Up Drug Prices

Faced with angry consumers and impending political reforms, the massive corporations that shape the way we pay for medicine are clamoring to preserve their public image, profit margins and political clout -- often by pointing the finger of blame at each other. The poster child for the debate is insulin, a hormone replacement drug that many people with diabetes need to stay alive. As Truthout has reported, the market price of popular insulin products has skyrocketed in recent years. Some people with diabetes go broke paying for their medicine. Others have died while attempting to ration dosages.

Keep reading... Show less